INCOME STATEMENT
Sun Pharma Advanced Research Company Ltd.
BSE
Jun 03
195.60
-2.85 ( -1.44%)
Volume
73862
Prev. Close
198.45
Open Price
199.75
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 03
195.18
-3.36 ( -1.69%)
Volume
1111200
Prev. Close
198.54
Open Price
199.45
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE232I01014
|
Market Cap. ( ₹ in Cr. )
|
6334.01
|
P/BV
|
-81.86
|
Book Value ( ₹ )
|
-2.38
|
|
BSE Code
|
532872
|
52 Week High/Low ( ₹ )
|
258/109
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
NSE Code
|
SPARCEQ
|
Book Closure
|
30/09/2020
|
EPS ( ₹ )
|
0.00
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 71.77 | 75.55 | 238.78 | 137.25 | 252.96 |
| Total Operating Revenues | 71.77 | 75.55 | 238.78 | 137.25 | 252.96 |
| | | | | | |
| Other Income | 1.79 | 29.47 | 10.88 | 6.84 | 5.41 |
| Total Revenue | 73.56 | 105.01 | 249.66 | 144.09 | 258.37 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 23.12 | 28.13 | 22.11 | 18.27 | 18.18 |
| Operating And Direct Expenses | 0.00 | 280.24 | 281.41 | 179.28 | 247.40 |
| Employee Benefit Expenses | 108.96 | 118.53 | 107.00 | 96.78 | 91.59 |
| Finance Costs | 8.91 | 1.66 | 7.63 | 13.33 | 10.65 |
| Depreciation And Amortisation Expenses | 10.83 | 12.13 | 11.77 | 10.16 | 10.92 |
| Other Expenses | 266.96 | 52.44 | 42.31 | 29.67 | 30.77 |
| Total Expenses | 418.78 | 493.12 | 472.24 | 347.49 | 409.51 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 |
| | | | | | |
| Profit/Loss Before Tax | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 |
| | | | | | |
| Profit/Loss From Continuing Operations | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 |
| | | | | | |
| Profit/Loss For The Period | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -10.64 | -11.96 | -7.82 | -7.73 | -5.77 |
| Diluted EPS (Rs.) | -10.64 | -11.96 | -7.82 | 7.73 | -5.77 |